Tablet

Taqtile Enhances Publishing Controls, Scalability in Latest Version of Manifest Work Instruction Platform

Retrieved on: 
Tuesday, April 2, 2024
Data Management, Apps, Applications, Technology, Other Technology, Software, Networks, IPad, Organization, Logic, Tablet, Knowledge, Publishing, 3D, Editorial, Multimedia, Microsoft HoloLens, HMDS, UI, Online shopping

Today, Taqtile , Inc. announces the availability of Manifest ® 3.0, providing new levels of control to organizations and enabling broad scalability, accountability, and improved regulatory compliance.

Key Points: 
  • Today, Taqtile , Inc. announces the availability of Manifest ® 3.0, providing new levels of control to organizations and enabling broad scalability, accountability, and improved regulatory compliance.
  • Manifest 3.0 provides greater, more sophisticated management of digitized work instructions, allowing organizations to efficiently control publication and access to spatially-enabled procedures for deskless employees worldwide.
  • View the full release here: https://www.businesswire.com/news/home/20240331017110/en/
    The Manifest 3.0 platform from Taqtile provides greater, more sophisticated management of digitized work instructions, allowing organizations to efficiently control publication and access to spatially-enabled procedures for deskless employees worldwide.
  • Publication of only a single work instruction at one time, ensuring an approved procedure is the only version available to workers performing the task.

Newegg Makes Tech More Affordable for Students, Faculty and Staff with Affirm Offer

Retrieved on: 
Thursday, March 28, 2024
Technology, Retail, Family, Consumer, Supply Chain Management, Electronic Commerce, Other Education, Payments, University, Primary, Secondary, Teens, Education, Consumer Electronics, Generation Z, Computer, Student, Tablet, Multimedia, Commerce, Faculty, Online shopping

Unique to the offer, the deal can be added to other promo codes and existing deals, maximizing total savings.

Key Points: 
  • Unique to the offer, the deal can be added to other promo codes and existing deals, maximizing total savings.
  • View the full release here: https://www.businesswire.com/news/home/20240328847282/en/
    Newegg is offering 10% off for students, faculty and staff with an .edu email when using Affirm.
  • Qualifying customers must pay over time with Affirm with promo code AFFIRMEDU at checkout to access the offer.
  • The Affirm offer is subject to eligibility and exclusions apply.1
    Newegg is a foremost resource for computers and laptops, especially among 18-24 year old customers.

Global Immune Health Supplements Outlook Report 2024: Market to Reach $34.73 Billion by 2028 with Amway, Bayer, DSM, Glanbia, Herbalife Nutrition, and Nutramax Laboratories Dominating - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 28, 2024
Vitamins, Supplements, Health, Capsule, Dicarboxylic acid, Attention, Bayer, Vitamin, Growth, Prevalence, Vitamin D, Infection, Amway, Dietary supplement, Printing, Probiotic, COVID-19, Zinc, DSM, Tablet, Calcium, Pharmacy, Selenium, Ageing, Pregnancy, Mineral, Protein, Mineral deficiency, Woman, Nutritional science, Immunity, Wound healing, Iron, Nutraceutical, Herbalife, Herbal, Supermarket

The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach $34.73 billion by 2028, growing at a CAGR of 8.92%

Key Points: 
  • The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach $34.73 billion by 2028, growing at a CAGR of 8.92%
    The global immune health supplements market is witnessing several dynamic changes after the Coronavirus surge worldwide.
  • In the global immune health supplements market, several leading domestic, national, and international vendors are present.
  • North America accounted for the highest global immune health supplements market share, accounting for over 33% in 2022.
  • High Demand for Immune Health Supplements with Zinc, Vitamin C & D, and Curcumins
    In the immune health supplements market, vitamin C, vitamin D, zinc, and curcumins are the most used and suggested ingredients for immune health.

Sexual Health Supplement Market Size, Share & Trends Analysis Report 2024: Natural Ingredients Lead Market Amid Preference for Organic Products - Global Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 26, 2024
Vitamins, Supplements, Other Health, Other Retail, Health, Retail, Dicarboxylic acid, Tablet, Prevalence, Human, Erectile dysfunction, Capsule, Application, COVID-19, Anxiety, Synthetic, NIH, King's College London, Parity, Nature, Safety, ED, Market, Dietary supplement

As per King's College London, ED is estimated that by 2025, 322 million men worldwide are expected to be affected by it.

Key Points: 
  • As per King's College London, ED is estimated that by 2025, 322 million men worldwide are expected to be affected by it.
  • Government-supported sexual health programs indeed have a significant impact on the market.
  • These programs help to increase awareness about sexual health issues, promote safe sex practices and encourage people to take proactive steps to maintain their sexual health.
  • For instance, Australia Department of Health has "Healthysexual" program, which raise awareness about sexual health.

Envoy Unveils Innovative Security Solutions to Secure Workplaces and Ensure Protection for Employees and Visitors

Retrieved on: 
Tuesday, March 26, 2024
Software, Technology, Data Management, Security, Facial recognition, Tablet, Multimedia, Workplace, Holiday, Safety, Online shopping

With this release, Envoy has extended workplace safety notifications to both employees and visitors , and announced visitor recognition and registration, and self-serve mobile visitor sign-in across multiple locations.

Key Points: 
  • With this release, Envoy has extended workplace safety notifications to both employees and visitors , and announced visitor recognition and registration, and self-serve mobile visitor sign-in across multiple locations.
  • Envoy’s latest features modernize security, safety, and compliance requirements, safeguarding against financial and reputational risks, including fines, lawsuits, and breaches.
  • "Businesses want a unified solution that can secure multiple office locations and remain compliant, without increasing costs or sacrificing user experience."
  • For more insights on why companies should modernize their security and compliance to safeguard workplaces, please read the Envoy Security Kit and the Workplace Security Report.

NTT Communications: Digital Event Connects Tokyo and Kanazawa via World's Longest IOWN APN to Commemorate Hokuriku Shinkansen Line's Extension

Retrieved on: 
Wednesday, March 27, 2024
Data Management, Consumer Electronics, Technology, Events, Concerts, Mobile, Wireless, Music, 5G, Entertainment, Metaverse, Rail, Security, Transport, Artificial Intelligence, Audio, Video, Telecommunications, IOT (Internet of Things), Software, Networks, Primary, Secondary, Internet, Education, NTT Communications, Wireless network, Communication, Environment, Internet of things, Tablet, NTT DOCOMO, APN, West Japan Railway Company, Nippon Telegraph and Telephone, NTT, Multimedia, Shinkansen, Hokuriku Shinkansen, Kanazawa Station, Mobile phone

For the connection, NTT Com provided its APN Leased Line Plan powered by IOWN,2 which used the longest optical cable ever deployed in an IOWN demonstration and the first to be deployed in Japan's Hokuriku region.

Key Points: 
  • For the connection, NTT Com provided its APN Leased Line Plan powered by IOWN,2 which used the longest optical cable ever deployed in an IOWN demonstration and the first to be deployed in Japan's Hokuriku region.
  • Kanazawa City provided the demonstration environment and operated the venue in its area and NTT Com provided the APN transmission equipment and the venue in Tokyo.
  • This was the first time in Japan that a metaverse space open to the public was used for a music event.
  • https://www.rd.ntt/e/iown/
    2 NTT Com began offering APN communication services spanning prefectures from March 1 to meet customers' needs for advanced communication infrastructure.

CHMP issues positive opinions for both bempedoic acid and the bempedoic acid / ezetimibe fixed-dose combination tablet as treatments for hypercholesterolaemia and significantly reducing cardiovascular events

Retrieved on: 
Friday, March 22, 2024
Health, Biometrics, General Health, Clinical Trials, Pharmaceutical, Cardiology, Biotechnology, Hypercholesterolemia, European Commission, Bempedoic acid, Risk, Patient, Tablet, Committee, ACL, Ageing, Agent handling, Esperion Therapeutics, EMA, Death, European Medicines Agency, Ezetimibe, Therapy, Moyamoya disease, ATP, FDC, CHMP, Apolipoprotein, Pharmaceutical industry

“The positive CHMP opinion is a crucial milestone towards improved treatment outcomes, as we are now able to address even better the unmet needs of cardiovascular care and prevention among patients in Europe.

Key Points: 
  • “The positive CHMP opinion is a crucial milestone towards improved treatment outcomes, as we are now able to address even better the unmet needs of cardiovascular care and prevention among patients in Europe.
  • This first-in-class medicine with proven efficacy in reducing hypercholesterolaemia and preventing cardiovascular risks, is a testament to our tireless efforts to help improve the cardiovascular treatment landscape.
  • The CHMP is a scientific committee of the EMA that reviews medical product applications on their scientific and clinical merit.
  • The European Commission will review the CHMP opinions and is expected to deliver its final decision in the mid of the year 2024.

U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use

Retrieved on: 
Friday, March 22, 2024
FDA, Health, Other Health, Pharmaceutical, Cardiology, Biotechnology, Photograph, Glucose, Urinary tract infection, Anaphylaxis, Myocardial infarction, Common, Bronchitis, Patient, European Medicines Agency, Ezetimibe, Therapy, Anemia, Pain, Sinusitis, Esperion Therapeutics, Bempedoic acid, Abdominal pain, Risk, Gout, Webcast, Committee, Spasm, Splenic infarction, ESPR, Back pain, ATP, Safety, Membrane protein, Fatigue, CHMP, Arthralgia, Angioedema, U.S. FDA, Cardiovascular disease, Kidney, Constipation, Death, Adverse event, Pregnancy, CLEAR, Rash, Rupture, Molina Healthcare, Hypersensitivity, Tablet, CVD, Incidence, Diarrhea, Fetus, Gallstone, Diet, Excipient, Upper respiratory tract infection, Multimedia, Uric acid, Dietary supplement

In addition, the enhanced labels support the use of NEXLETOL and NEXLIZET either alone or in combination with statins.

Key Points: 
  • In addition, the enhanced labels support the use of NEXLETOL and NEXLIZET either alone or in combination with statins.
  • They also include new indications for primary hyperlipidemia, alone or in combination with a statin, and are the only LDL-C lowering non-statin drugs indicated for primary prevention patients.
  • View the full release here: https://www.businesswire.com/news/home/20240322544788/en/
    U.S. FDA approves broad new labels for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets to prevent heart attacks and cardiovascular procedures in both primary and secondary prevention patients, regardless of statin use.
  • CLEAR Outcomes is part of the CLEAR clinical research program for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet.

Global Digital Biomarkers Market Outlook & Forecast 2024-2029: Rise in Digitized Virtual Clinical Research, Increasing Focus on Drug Development and Expanding Applications in Mental Health - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 21, 2024
Mobile, Wireless, Other Technology, Telecommunications, Other Science, Data Analytics, Pharmaceutical, Research, Hardware, Mental Health, Medical Devices, Data Management, Consumer Electronics, Wearables, Mobile Technology, Technology, Women, Science, Biotechnology, Seniors, Biometrics, Medical Supplies, Men, Health, Artificial Intelligence, Health Technology, Professional Services, Health Insurance, Consumer, Cardiology, Culture, Conditional sentence, Growth, Prevalence, Neurology, Digital, Vital signs, COVID-19, Patient, Heart rate, Tablet, Biomarker, Health care, Software, Diagnosis, Drug development, USD, Ageing, Medical imaging

Factors such as an aging population, increasing healthcare costs, and a shift towards value-based care have driven the adoption of digital biomarkers.

Key Points: 
  • Factors such as an aging population, increasing healthcare costs, and a shift towards value-based care have driven the adoption of digital biomarkers.
  • The rise in digitized virtual clinical research is a significant trend in the global digital biomarkers market, driven by advances in remote monitoring technologies and the need for more efficient, patient-centric clinical trials.
  • The global digital biomarkers market is witnessing a notable trend with an increasing focus on drug development.
  • A prominent trend in the global digital biomarkers market is the increasing number of vendor collaborations and partnerships.

Tiny, Micropower Hall-Effect Switches from Diodes Incorporated Deliver Compatibility with Low-Voltage Chipsets

Retrieved on: 
Thursday, March 21, 2024
Semiconductor, Hardware, Consumer Electronics, Mobile, Wireless, Technology, Temperature, Tablet, DIOD, Type, PCB, BOP, BRP, Electronics

Diodes Incorporated (Diodes) (Nasdaq: DIOD) introduces three new Hall-effect switches, the AH1899A/B/S , which operate from a low supply voltage and at extremely low quiescent current to extend battery lifetime in mobile and portable devices.

Key Points: 
  • Diodes Incorporated (Diodes) (Nasdaq: DIOD) introduces three new Hall-effect switches, the AH1899A/B/S , which operate from a low supply voltage and at extremely low quiescent current to extend battery lifetime in mobile and portable devices.
  • They are also designed for proximity detection in digital cameras and handheld gaming consoles, as well as general contactless switching.
  • These switches, with their supply-voltage range of 1.1V to 2.0V, seamlessly integrate with state-of-the-art application chipsets operating at 1.2V, ensuring ease of use.
  • The hibernating clocking system in these switches help maximize system energy savings to extend the runtime of battery-operated devices.